Brain and its Effect on GABA A Receptor Binding: Takehiko ITO, et al. Faculty of Education, Okayama University-Organic solvents generally depress the central nervous system (CNS), similarly to volatile anesthetics. The precise mechanism of their action on the CNS, however, is not fully understood, and remains to be clarified. This study is focused on how inhaled m-xylene distributes in the brain, and whether region specific change in GABA A receptor binding takes place due to the exposure. To conduct this study, we first developed a simple exposure system suitable for inhalation experiments with small animals. Using this system, six-week-old male Sprague-Dawley rats were exposed to m-xylene vapor (2000 ppm) 4 h/d, for 5 consecutive days. At the end of the exposure, m-xylene levels in four different regions of the brain were measured by head-space gas chromatography. Also 14 µm-thick frozen sections of the brain were made, and [
Despite the usefulness of organic solvents in industries, uncontrolled use of solvents may be hazardous to workers because of their acute and chronic toxicity 1) . Pharmacologically, organic solvents are generally central nervous system (CNS) depressants, and similar to volatile anesthetics. Because of their lipophilicity, they distribute in lipid-rich organs such as the brain, which is one of the main targets of the action of organic solvents. The neurotoxicity of organic solvents including xylene has been well documented 1, 2) and recommendation of occupational exposure limits has been established 3) . Nevertheless, the molecular aspects of the mechanisms of neurotoxicity of organic solvents are not fully understood. It seems that the brain with so many possible targets of organic solvent's action (e.g. the GABA system [4] [5] [6] , catecholamine system including the dopamine system 7, 8) ) makes the general picture of the neurotoxic mechanism complicated.
In the present study we developed an exposure system suitable for inhalation experiments on small animals. With this system we exposed rats acutely to m-xylene, and examined the region specific distribution of inhaled m-xylene in the brain, as well as the distribution in other organs and tissues. In this way we have attempted to show whether m-xylene is evenly distributed in the brain or not. Because the functions of the brain are localized in discrete areas, the distribution of inhaled m-xylene in the brain was of particular interest.
Several lines of evidence [4] [5] [6] show that toluene and other organic solvents affects GABA A receptor, and we considered that m-xylene would have a similar effect. We therefore focused on the GABA system to elicit a possible effect of m-xylene on the CNS. We have hypothesized that if inhaled m-xylene has an effect on GABA A receptors, GABA A receptor-related binding might change, and consequently the change could be visualized with the receptor binding autoradiography technique. We expected that the spatial distribution of GABA A receptors shown in an autoradiogram could be referenced with the data on the distribution of inhaled m-xylene.
Materials and Methods

Animals
Six-week-old male Sprague-Dawley rats (Japan Clea, Tokyo, Japan) were used. They were housed under standard laboratory conditions and were fed rat chow and water ad libitum. The experiment was carried out in accordance with The Guidelines for Animal Experiments in Okayama University Medical School.
Chemicals
We purchased m-xylene from Nacalai Tesque (Kyoto, Japan), compressed air (medical grade) from Daido A i r S y s t e m s ( O k a y a m a , J a p a n ) a n d [
35 S ] tbutylbicyclophosphorothionate (TBPS; 87.4 Ci/mmol) from New England Nuclear (Boston, MA), respectively. All other chemicals were of the highest grade available from commercial suppliers.
Exposure of animals to m-xylene
The exposure system shown in Fig. 1 was made for this experiment. An exposure chamber (40 × 30 × 25 cm) was connected to a vaporizer for clinical ether anesthesia (model #775, Igarashi Medical Equipments, Tokyo, Japan). Fresh air (flow rate 4-6 l/min; c.a. 10 air changes/h) was supplied from a gas container. The concentration of m-xylene was monitored with a flammable gas monitor (model XP-316, New Cosmos Electric, Osaka, Japan). Rats were exposed to m-xylene at 2000 ppm, 4 h/d for 5 consecutive days. No more than 4 animals were placed in the chamber, and they were given no food or water during the exposure. The concentration of m-xylene was read every 2 min for the first 25 min to reach the target concentration, and every 5 min thereafter. The concentration was manually controlled throughout the exposure. Control animals underwent identical procedures but received air without m-xylene.
Preparation of samples for measurement of the m-xylene concentration
At the end of the fifth exposure, the rats were anesthetized with ether, and decapitated. The brain was removed rapidly, and dissected into seven regions according to the method of Glowinski and Iversen 9) . The dissected brain regions were grouped as follows: A: cerebral cortex, B: midbrain + striatum + hippocampus + hypothalamus, C: cerebellum, D: pons-medulla oblongata (Fig. 2a) . Each sample was wrapped with vinylidene chloride polymer film (Saran Wrap; Asahi Kasei, Tokyo, Japan) 10) , placed in a tightly sealed container, and kept at 50°C until the m-xylene concentration was measured. The lungs, heart, liver, kidney, spleen, testis, psoas muscle, peri-intestinal fat and subcutaneous fat were also removed and stored in the same way as the brain samples until the measurement procedure. 
Measurement of m-xylene concentration by gas chromatography (GC)
Each sample was weighed in a glass vial. Then 2.5 ml of 1N NaOH, 0.5 ml of 20% (v/v) olive oil, and 10 µl of toluene methanol solution (internal standard; 10 mg/ml) were added. The vial was tightly sealed, shaken for 90 min at 55°C, and placed at room temperature for more than one h. The gas phase in the headspace was subjected to GC. About 0.1-0.2 mg of reference material with 10 µl of m-xylene methanol solution (10 mg/ml) was used to obtain a reference peak. The condition for GC analysis was as follows: Equipment: GC-4CM with FID (Shimadzu, Tokyo, Japan); Column: 25% PEG-1000, φ 3.0 mm × 2 m; Temperature: 100°C (column), 110°C (injector and detector); Carrier gas N 2 : (flow rate 60 ml/ min). The concentration of m-xylene in each sample was calculated by the following equation:
× 100 / (sample weight) (A xs : peak area of m-xylene in the sample; A ts : peak area of toluene in the sample; A xc : peak area of m-xylene in the reference; A tc : peak area of toluene in the reference).
[
S]TBPS binding autoradiography
Each brain was rapidly frozen in liquid nitrogen, and 14 µm-thick frozen sections were made using a cryostat. These sections were thaw-mounted onto gelatin-coated slides, and kept at 80°C until the assay.
Receptor binding autoradiography was done according to the previously described method 11) with a slight modification. In short, sections were pre-incubated in 50 mM phosphate buffer (pH 7.4) with 1 mM EDTA at 22°C for 10 min. The sections were incubated in 50 mM phosphate buffer (pH 7.4) with 1 mM EDTA and 3 nM [ 35 S]TBPS at 22°C for 180 min. They were rinsed in 50 mM phosphate buffer (pH 7.4) with 1mM EDTA at 22°C for 5 min, twice, and dipped in distilled water to remove buffer salt. The slides were dried rapidly under a stream of cold air, and were further dried overnight at room temperature. The slides were apposed to an autoradiography film (Kodak XAR, Rochester, NY) for three days with a set of plastic strips with known amounts of 14 C as an internal standard (ARC146, ARC, St. Louis, MO). The film was processed by standard procedures, and was analyzed with a digital scanning densitometer (Scanning Imager 300SX, Molecular Dynamics, Sunnyvale, CA), operating on image acquisition program ImageQuant 3.0 (Molecular Dynamics, Sunnyvale, CA).
Results
Exposure system
The exposure system that we developed in the present study produced a stable environment suitable for conducting inhalation experiments on small animals such as rats or mice. The vaporizer was capable of supplying air that contained m-xylene at a steady concentration ranging from 100 to 2200 ppm at 22°C. During the steady-state exposure, the m-xylene concentration in the exposure chamber was 2000 ± 40 ppm (mean ± SD of 44 samples). The gradient of concentrations of m-xylene within the exposure chamber was 2000 ± 15 ppm (mean ± SD of 36 sampling points). The relative humidity in the chamber was 72-82%.
Concentration of m-xylene in the brain
Measurements of m-xylene concentrations in four regions of the brain were conducted by head-space GC. As shown in Fig. 2b , the m-xylene concentration in region A significantly differed from those in regions B and C, which showed that inhaled m-xylene was distributed unevenly in the brain. The highest concentration was observed in region C (cerebellum), and the lowest concentration was observed in region A (cerebral cortex). No m-xylene was detected in the brains of the control animals. 
Concentration of m-xylene in various organs and tissues
Concentrations of m-xylene in various organs and tissues were also measured in a similar manner. Table 1 shows the distribution of m-xylene in various organs and tissues. The concentration of m-xylene was much higher in adipose tissue such as peri-intestinal fat and subcutaneous fat than in other organs.
S]TBPS binding autoradiography
In order to observe the effects of m-xylene on GABA A receptor binding, we conducted a receptor binding study using [
35 S]TBPS as a labeled ligand. Fig. 3 shows a typical autoradiogram. The IVth layer of the cerebral cortex and the molecular layer of the cerebellum showed relatively larger ligand binding than in other regions, which was consistent with previous studies 11, 12) . With this autoradiogram, [
35 S]TBPS binding in 10 regions of the brain was examined (Fig. 4) . The m-xylene-exposed rats showed significantly higher [
35 S]TBPS binding in the molecular layer of the cerebellum.
Discussion
The present study was focused on three major points. To develop a simple apparatus to conduct inhalation studies on small animals was the first point. We have utilized a vaporizer for clinical ether anesthesia to obtain air with a stable concentration of organic solvents. Our apparatus was capable of producing a wide range of mxylene concentrations (100 to about 2200 ppm at 22°C). The system can afford to supply airflow containing reproducible concentrations of organic solvent vapor, and is easy to handle. We considered that it would be a useful one for researchers that need an exposure chamber for such experiments.
To know the distribution of inhaled m-xylene in various organs, especially in the brain, was the second point. Inhaled m-xylene was unevenly distributed in the four regions of the rat brain. The highest concentration was observed in the cerebellum, and it was about two-fold of that in the cerebral cortex (Fig. 2b) . We speculate that the time constant of the increase in the m-xylene concentration under the exposure might vary among different regions of the brain. Regional difference in blood flow or in lipid composition might result in this difference in the time constant, and another experiment is now being conducted to prove the hypothesis.
Among other organs and tissues, adipose tissue showed a marked concentration of m-xylene (above 2500 µg/g tissue) while all organs tested showed m-xylene concentrations lower than 100 µg/g tissue (Table 1) . These results suggested that, in general, there were higher m-xylene concentrations in tissues rich in lipids. These findings in rats were partially in accordance to the report of Yoshitome et al. 13) , which describes the autopsy of a victim of an accidental inhalation of toluene. The pattern of distribution of toluene in the victim's body looked similar to the distribution of m-xylene in the rat's body. In the brain, however, toluene concentrations in the victim's cerebrum and brain stem were very close (465.4 µg/g tissue and 437.9 µg/g tissue, respectively) and differ from our observation of m-xylene concentrations in the rat brain. This difference may be due to the difference in Unit: µg/g wet tissue; N.D.: not detected. Each value represents the mean ± SEM for 6-8 animals. *Data the same as those shown in Fig. 2 . 35 S]TBPS binding in the rat brain has been well described 12) . It has been reported that many substances that modify the function of GABA A receptor may alter GABA A receptor binding including [
35 S]TBPS binding 14, 15) . [ 35 S]TBPS binds to the picrotoxin/convulsant binding site of GABA A receptors, and the increase in the binding may be attributed to functionally down-regulated GABA A receptors 15) . As shown in Fig. 4, [ 35 S]TBPS binding was significantly increased in the molecular layer of the cerebellum. It has been reported that toluene increases GABA release in the cerebellum 5) . This increase in GABA release seems to occur in the GABAergic interneurons (e.g. basket, stellate and Golgi cells), possibly as a result of enhanced input from afferent fibers 5) . In addition, toluene enhances GABA A receptor function 6) . Taken together, both presynaptic and postsynaptic enhancement of GABAergic transmission is possible by the action of toluene. The GABA A receptors that may be functionally down-regulated by the above mechanisms exist mostly in the molecular layer of the cerebellum. If the action of m-xylene is similar to that of toluene, it is possible that m-xylene at a high concentration in the cerebellum increased GABA release, and/or enhanced GABA A receptor function, which consequently altered GABA A receptor binding in the molecular layer of the cerebellum.
Although region B (i.e., midbrain, hippocampus, hippocampus + hypothalamus) contained an m-xylene concentration close to that of the cerebellum, no change in [ 35 S]TBPS binding was detected in this area. Therefore, the effect of m-xylene might be region specific. GABA A receptors are made of 5 subunits, and these subunits are distributed heterogeneously in the brain 13) . If the effect of m-xylene were subunit specific, the susceptibility to m-xylene might vary in discrete brain areas due to difference in the components of the receptors. This hypothesis may be studied by using subunit specific ligands such as [ 3 H]Ro15-4513 16) , and is now under investigation.
The present results seem to shed light on m-xylene's action on cerebellar function. It has been reported that all isomers of xylene disrupt motor coordination 17) in mice, whereas xylene decreases locomotor activity 18) in rats. Moreover, alkylbenezenes including m-xylene cause various neurobehavioral changes (e.g., gait abnormalities) in rats that are similar to the action of pentobarbital 19) . In humans, acute exposure to xylene at lower doses (90 or 200 ppm, 6 h/d, 6 d) causes impairment of body balance and manual coordination 1) . Xylene modifies n-hexane's effect on subclinical cerebellar dysfunction in humans assessed by postural sway frequency analysis 20) . These neurobehavioral effects in laboratory animals and in humans are, at least in part, related to altered cerebellar function. Because GABAergic neurotransmission plays an important role in inhibitory transmission in the cerebellum, changes in this system may result in these neurobehavioral changes. In fact, several lines of evidence show that toluene affects performance of the vestibulo-oculomotor system in rats 21, 22) , and the effect is modified by alteration of GABA transmission both presynaptically (with GABA B receptor agonist and antagonist 21, 22) ) and postsynaptically (with GABA A receptor agonist 21) ). By analogy, m-xylene may also modify the cerebellar function through GABA transmission in a receptor specific mechanism. A further study on this matter is therefore warranted.
The authors intend to extend this study with different exposure protocols (e.g., duration of exposure, m-xylene concentration) to clarify the dose-response of the change in GABA A receptor binding. We are also going to correlate the urinary concentration of the metabolite of m-xylene (i.e. m-methylhippuric acid) with neurochemical findings so that we would be able to develop a new method of biological effect monitoring of organic solvent inhalation. This point is especially important because methylhippuric acid normally does not exist in human urine, and that any methylhippuric acid in urine would directly reflect the intensity of inhalation.
In conclusion, when rats were exposed to m-xylene at 2000 ppm for 4 h/d for 5 consecutive days, the levels of m-xylene ranged from 27 ± 7.8 µg/g (lung) to 2984 ± 579 µg/g (subcutaneous fat). In the brain, m-xylene was unevenly distributed, and the highest level was observed in the cerebellum.
[ 35 S]TBPS binding was significantly increased in the molecular layer of the cerebellum, which indicates a possible action of m-xylene on GABA A receptors.
